218 related articles for article (PubMed ID: 1465854)
1. Current experience with renal transplantation across the ABO blood group barrier.
Bryan CF; Nelson PW; Aeder MI; Beck ML; Helling TS; Hughes TM; Luger AM; Pierce GE; Shield CF
Transplant Proc; 1992 Dec; 24(6):2527-9. PubMed ID: 1465854
[No Abstract] [Full Text] [Related]
2. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
[No Abstract] [Full Text] [Related]
3. Relevance of positive crossmatches in renal transplantation.
Horsburgh T; Mistry N; Weston S; Morgan J; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2508-9. PubMed ID: 1465848
[No Abstract] [Full Text] [Related]
4. Outcome of donor-specific skin graft is a reliable prognostic sign in ABO-incompatible live-donor renal transplants.
Haberal M; Tokyay R; Bilgin N
Transplant Proc; 1992 Dec; 24(6):2530-1. PubMed ID: 1465855
[No Abstract] [Full Text] [Related]
5. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
Velidedeoğlu E; Tokyay R; Haberal M
Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
[No Abstract] [Full Text] [Related]
6. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
Martin S; Dyer PA; Scott PD
Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
[No Abstract] [Full Text] [Related]
7. Patterns of "hidden" humoral allosensitization to HLA-A2 revealed by a simple modification of the standard lymphocytotoxic test.
Bohinjec M; Vidan B
Transplant Proc; 1992 Dec; 24(6):2497-501. PubMed ID: 1465844
[No Abstract] [Full Text] [Related]
8. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
[No Abstract] [Full Text] [Related]
9. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
[No Abstract] [Full Text] [Related]
10. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
[No Abstract] [Full Text] [Related]
11. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
12. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
[No Abstract] [Full Text] [Related]
13. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
14. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation.
Ishida H; Tanabe K; Ishizuka T; Furusawa M; Miyamoto N; Ishikawa N; Shirakawa H; Shimmura H; Ishii D; Nozaki D; Setoguchi K; Toma H
Transplantation; 2006 Mar; 81(5):665-71. PubMed ID: 16534466
[TBL] [Abstract][Full Text] [Related]
15. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
Middleton D; Martin J; Magee BA; Douglas JF
Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
[No Abstract] [Full Text] [Related]
16. Is superior graft survival of multiorgan donor kidneys due to better preservation or better organ selection?
Albrecht KH; Rudy T; Niebel W; Eigler FW
Transplant Proc; 1992 Dec; 24(6):2748-9. PubMed ID: 1465925
[No Abstract] [Full Text] [Related]
17. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
18. In vitro B cell response in long-term renal transplant recipients.
Weimer R; Zipperle S; Daniel V; Pomer S; Staehler G; Opelz G
Transplant Proc; 1992 Dec; 24(6):2537-8. PubMed ID: 1465858
[No Abstract] [Full Text] [Related]
19. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
[No Abstract] [Full Text] [Related]
20. Current experience with renal transplantation across the ABO barrier.
Nelson PW; Helling TS; Shield CF; Beck M; Bryan CF
Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
